Trending News
News
News
Vaccine Antibody Levels Start To Decline After 2–3 Months
A study has shown that total antibody levels appear to start declining from as early as six weeks after complete vaccination and can reduce by more than 50% over 10 weeks.
News
New Optogenetic Tool: Light Switches Protein “Off”
A new optogenetic tool, a protein that can be controlled by light, has been characterized by researchers at Ruhr-Universität Bochum (RUB).
News
Managing Diabetes: Pairing Basal Insulin With Continuous Glucose Monitoring
A study of 175 patients with poorly controlled type 2 diabetes found that continuous glucose monitoring, compared to blood glucose meter monitoring significantly decreased their hemoglobin A1C over eight months.
News
AI Cancer Models Can Make Biased Predictions Unless Calibrated Properly
Artificial intelligence and deep learning models are powerful techniques in cancer treatment. However, unless these algorithms are properly calibrated, they can make inaccurate or biased predictions.
News
mRNA COVID-19 Vaccines: Safety of Second Dose Following First-Dose Allergic Reactions
A multicenter, retrospective study has been conducted to assess the safety of a second dose of mRNA COVID-19 vaccine in patients with allergic reactions to the first dose. All patients with allergic reactions to the first dose, who went on to receive a second dose, safely completed their course, with 20% reporting mild symptoms.
News
Discovery of Repair Process in the Brain Could Lead to New Epilepsy Treatments
Researchers have uncovered a repair process within the brain that they hope could be exploited to treat seizure-related brain injuries.
News
Advantages of Intranasal Delivery of COVID-19 Vaccines
Research shows that intranasal vaccination elicits immunity at the site of infection, the respiratory tract.
News
Organ-on-a-Chip Finds Crucial Connection Between Blood and Ovarian Cancers
Researchers have developed an organ-on-a-chip device that could change the way clinicians approach cancer treatment, particularly ovarian cancer.
News
Gene Therapy Provides Neuroprotection and Prevents Vision Loss in Glaucoma Model
Researchers have found that the calcium modulator, CaMKII, protects the optic nerve in mice, opening the door to new sight-saving therapy.
News
Team Therapeutically Targets Mutation Causing Devastating Childhood Cancer
Researchers have discovered how a specific genetic mutation (H3K27M) causes an incurable childhood cancer called diffuse midline glioma (DMG). In laboratory studies working with cell models, they were able to successfully reversed its effects to slow cancer cell growth with a targeted drug.
Advertisement